FLT3 and chronic myelogenous leukemia, BCR-ABL1 positive: Hence, as in CML [46-48] and FLT-3 mutant [49] AML cells, Bim is also emerging as a central cell death driver in JAK2V617F mutant cells ([21], and this report).